DeepLife Company
DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.
Investors
Industry:
AI, Early Drug Development
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2019-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
5
Total Funding:
6000000
Last Funding Date:
2022-09-02
Last Funding Type:
Series A
Register and Claim Ownership